factual
Statins carry small real type 2 diabetes risk
Statins (but not PCSK9 inhibitors, ezetimibe, or bempedoic acid) carry a small but real increased risk of type 2 diabetes, and a larger number of people become somewhat more glucose intolerant on statins—detectable via continuous glucose monitor but obscured on hemoglobin A1c—so patients showing a 5-10 point CGM change may be switched off statins despite tolerating them.
factualpending
Speaker
Peter AttiaEvidence Quote
“we have had a number of patients that we've taken off statins even though they've ostensibly tolerated them because we see a five or 10 point change on their on their cgm”
Created: 6/14/2026, 2:19:52 AM
Your notes
Loading notes...